Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 8,9-EET cPLA2i 1.0 BCD110605C16 0.076 pmol/ml of medium
- 8,9-EET cPLA2i 1.0 BCD110605C18 0.084 pmol/ml of medium
- 8,9-EET cPLA2i 1.0 BCD110605C17 0.077 pmol/ml of medium
- 8,9-EET cPLA2i 4.0 BCD110605C34 0.086 pmol/ml of medium
- 8,9-EET cPLA2i 4.0 BCD110605C36 0.096 pmol/ml of medium
- 8,9-EET cPLA2i 4.0 BCD110605C35 0.099 pmol/ml of medium
- 8,9-EET cPLA2i 20.0 BCD110605C53 0.016 pmol/ml of medium
- 8,9-EET cPLA2i 20.0 BCD110605C54 0.008 pmol/ml of medium
- 8,9-EET cPLA2i 20.0 BCD110605C52 0.035 pmol/ml of medium
- 8,9-EET PLDi 1.0 BCD110605C10 0.047 pmol/ml of medium
- 8,9-EET PLDi 1.0 BCD110605C12 0.068 pmol/ml of medium
- 8,9-EET PLDi 1.0 BCD110605C11 0.09 pmol/ml of medium
- 8,9-EET PLDi 4.0 BCD110605C30 0.082 pmol/ml of medium
- 8,9-EET PLDi 4.0 BCD110605C29 0.072 pmol/ml of medium
- 8,9-EET PLDi 4.0 BCD110605C28 0.062 pmol/ml of medium
- 8,9-EET PLDi 20.0 BCD110605C48 0.013 pmol/ml of medium
- 8,9-EET PLDi 20.0 BCD110605C47 0.032 pmol/ml of medium
- 8,9-EET PLDi 20.0 BCD110605C46 0.013 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 1.0 BCD110605C19 0.125 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 1.0 BCD110605C21 0.12 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 1.0 BCD110605C20 0.107 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 4.0 BCD110605C39 0.374 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 4.0 BCD110605C37 0.371 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 4.0 BCD110605C38 0.478 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 20.0 BCD110605C55 0.197 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 20.0 BCD110605C57 0.302 pmol/ml of medium
- 8,9-EET KDO+cPLA2i 20.0 BCD110605C56 0.227 pmol/ml of medium
- 8,9-EET KDO+PLDi 1.0 BCD110605C15 0.177 pmol/ml of medium
- 8,9-EET KDO+PLDi 1.0 BCD110605C14 0.122 pmol/ml of medium
- 8,9-EET KDO+PLDi 1.0 BCD110605C13 0.135 pmol/ml of medium
- 8,9-EET KDO+PLDi 4.0 BCD110605C32 0.452 pmol/ml of medium
- 8,9-EET KDO+PLDi 4.0 BCD110605C31 0.493 pmol/ml of medium
- 8,9-EET KDO+PLDi 4.0 BCD110605C33 0.538 pmol/ml of medium
- 8,9-EET KDO+PLDi 20.0 BCD110605C49 0.323 pmol/ml of medium
- 8,9-EET KDO+PLDi 20.0 BCD110605C51 0.451 pmol/ml of medium
- 8,9-EET KDO+PLDi 20.0 BCD110605C50 0.507 pmol/ml of medium
- 8,9-EET KDO + ATP 1.0 BCD110605C07 0.15 pmol/ml of medium
- 8,9-EET KDO + ATP 1.0 BCD110605C09 0.171 pmol/ml of medium
- 8,9-EET KDO + ATP 1.0 BCD110605C08 0.153 pmol/ml of medium
- 8,9-EET KDO + ATP 4.0 BCD110605C25 0.574 pmol/ml of medium
- 8,9-EET KDO + ATP 4.0 BCD110605C26 0.648 pmol/ml of medium
- 8,9-EET KDO + ATP 4.0 BCD110605C27 0.407 pmol/ml of medium
- 8,9-EET KDO + ATP 20.0 BCD110605C45 0.353 pmol/ml of medium
- 8,9-EET KDO + ATP 20.0 BCD110605C43 0.2 pmol/ml of medium
- 8,9-EET KDO + ATP 20.0 BCD110605C44 0.294 pmol/ml of medium
- 8,9-EET C 0.0 BCD110605C02 0.05 pmol/ml of medium
- 8,9-EET C 0.0 BCD110605C01 0.03 pmol/ml of medium
- 8,9-EET C 0.0 BCD110605C03 0.053 pmol/ml of medium
- 8,9-EET C 1.0 BCD110605C06 0.069 pmol/ml of medium
- 8,9-EET C 1.0 BCD110605C05 0.05 pmol/ml of medium